Pharmanutra S.p.A.'s latest marketcap:
As of 06/06/2025, Pharmanutra S.p.A.'s market capitalization has reached $556.72 M. According to our data, Pharmanutra S.p.A. is the 13046th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 556.72 M |
| Revenue (ttm) | 132.29 M |
| Net Income (ttm) | 18.92 M |
| Shares Out | 9.6 M |
| EPS (ttm) | 1.97 |
| Forward PE | 22.39 |
| Ex-Dividend Date | 05/05/2025 |
| Earnings Date | 09/08/2025 |
Pharmanutra S.p.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | €488.81 M | -5.74% |
| 12/30/2024 | €522.67 M | -3.62% |
| 12/29/2023 | €542.32 M | -9.76% |
| 12/30/2022 | €600.96 M | -17.67% |
| 12/30/2021 | €729.95 M | 100.53% |
| 12/30/2020 | €364 M |
Company Profile
About Pharmanutra S.p.A.
Pharmanutra S.p.A. is a pharmaceutical and nutraceutical company specializing in the research, design, development, and marketing of nutritional supplements and medical devices. The company operates globally, with a presence in Italy, Europe, the Middle East, South America, the Far East, and other international markets.
Product Portfolio
Pharmanutra offers a diverse range of products, including:
- SiderAL (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, and SiderAL Med)
- Cetilar (Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition)
- ApportAL
- UltraMag
- Gestalys DHA
- Novomega
- Bonecal
- DiKappa 2
The company also produces pharmaceuticals, medical devices, OTC products, and nutraceuticals for the pediatric sector. Additionally, it supplies raw materials and active ingredients for the food, pharmaceutical, and food supplement industries.
Distribution & Sales
Pharmanutra distributes its products through multiple channels, including:
- Sales representatives
- Wholesalers
- Pharmacies
- Para-pharmacies
Company Background
Founded in 2003, Pharmanutra S.p.A. is headquartered in Pisa, Italy.
Frequently Asked Questions
-
What is Pharmanutra S.p.A.'s (BIT-PHN) current market cap?As of 06/06/2025, Pharmanutra S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $556.72 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Pharmanutra S.p.A. (BIT-PHN) rank globally by market cap?Pharmanutra S.p.A. global market capitalization ranking is approximately 13046 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.